IGE Full details for md exams 10 marks answer from murray only
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have all the key data I need from Harper's (Murray). Let me compose a full 10-mark exam answer on IgE.
IgE (Immunoglobulin E) - Full Details
Source: Harper's Illustrated Biochemistry, 32nd Edition (Murray et al.)
Introduction
IgE is one of the five classes of human immunoglobulins (IgA, IgD, IgE, IgG, IgM). It is the least abundant immunoglobulin in serum but plays a central role in immediate (Type I) hypersensitivity reactions and defense against parasitic infections.
(Harper's Biochemistry, 32nd Ed, p. 658)
Structure of IgE
- Heavy chain: The epsilon (ε) chain - unique to IgE
- Light chains: Two κ or two λ chains (like all immunoglobulins)
- Structure: Monomer (basic Y-shaped tetrameric unit - two H chains + two L chains)
- Molecular weight: ~190,000 Da (190 kDa)
- Sedimentation coefficient: 8S
- Domain organization: The ε chain contains four constant-region domains (C_H1, C_H2, C_H3, C_H4) - unlike IgG which has only three. This extra domain is shared only with IgM among the immunoglobulin classes.
(Harper's Biochemistry, 32nd Ed, p. 658)
Properties of IgE (Comparative Table from Murray)
| Property | IgE |
|---|---|
| Percentage of total serum immunoglobulin | 0.004% (least abundant) |
| Serum concentration | ~0.05 mg/dL |
| Sedimentation coefficient | 8S |
| Molecular weight | 190 kDa |
| Structure | Monomer |
| Heavy chain symbol | ε (epsilon) |
| Complement fixation | No |
| Transplacental passage | No |
| Mediation of allergic responses | Yes (unique to IgE) |
| Found in secretions | No |
| Opsonization | No |
| Antigen receptor on B cell | No |
(Harper's Biochemistry, 32nd Ed, Table 52-8, p. 658)
Biologic Function of IgE
From Murray's Table 52-9, the function of IgE is clearly stated:
"Mediates immediate hypersensitivity reactions (allergy) via binding to mast cells and basophils."
The mechanism involves:
- Sensitization phase: On first exposure to an allergen, B cells undergo class switching to produce IgE antibodies specific for that allergen.
- IgE binding to Fc receptors: IgE binds via its Fc region (the C_H2/C_H3/C_H4 domains) to high-affinity FcεRI receptors on the surface of mast cells and basophils. This sensitizes these cells.
- Re-exposure and cross-linking: On subsequent exposure, the allergen cross-links two or more cell-bound IgE molecules. This cross-linking of IgE on FcεRI receptors triggers cellular activation and degranulation.
- Mediator release: Degranulation releases preformed mediators including histamine, heparin, proteases (tryptase), and leads to synthesis of newly formed mediators such as leukotrienes and prostaglandins.
- Clinical manifestations: These mediators produce the features of immediate hypersensitivity - bronchoconstriction, vasodilation, increased vascular permeability, smooth muscle contraction, mucus secretion (urticaria, angioedema, asthma, anaphylaxis).
(Harper's Biochemistry, 32nd Ed, p. 658-660)
Constant Regions and Effector Functions
The constant regions of immunoglobulins (particularly C_H2 and C_H3, and C_H4 of IgM and IgE) on the Fc fragment are responsible for class-specific effector functions. For IgE, these include:
- Binding to FcεRI on mast cells and basophils
- Binding to low-affinity FcεRII (CD23) on B cells, monocytes, and eosinophils
- IgE-mediated eosinophil activation (important in parasitic infections and allergic inflammation)
(Harper's Biochemistry, 32nd Ed, p. 659)
Clinical Significance of IgE
| Condition | IgE Relevance |
|---|---|
| Allergic rhinitis, asthma, urticaria | Elevated total and specific IgE; Type I hypersensitivity |
| Anaphylaxis | Massive mast cell/basophil degranulation via IgE |
| Atopic dermatitis (eczema) | Elevated total IgE levels |
| Helminth (parasitic worm) infections | IgE produced in high amounts; eosinophil activation |
| Allergic bronchopulmonary aspergillosis (ABPA) | Total IgE >1000 IU/mL is a diagnostic criterion |
| Hyper-IgE syndrome (Job's syndrome) | Markedly elevated IgE with recurrent staphylococcal abscesses, eczema, and pneumatoceles |
Anti-IgE Therapy
Omalizumab is a recombinant humanized monoclonal antibody that binds free IgE, preventing it from binding to FcεRI receptors on mast cells and basophils. It is used in:
- Moderate-to-severe allergic asthma
- Chronic idiopathic urticaria
Summary Points for 10-Mark Answer
- IgE is a monomer with ε heavy chains and MW ~190 kDa
- It is the least abundant immunoglobulin (0.004% of total; serum conc ~0.05 mg/dL)
- It has four C_H domains (shared with IgM) instead of the usual three
- It does not fix complement, cross the placenta, or function as a B-cell antigen receptor
- Its sole major function is mediation of immediate (Type I) hypersensitivity via mast cells/basophils
- Mechanism: Allergen → IgE production → IgE binds FcεRI on mast cells → re-exposure cross-links IgE → degranulation → histamine, leukotrienes → allergic symptoms
- Also plays a role in anti-parasitic immunity (eosinophil activation)
- Elevated in atopy, ABPA (>1000 IU/mL diagnostic), hyper-IgE syndrome
- Omalizumab (anti-IgE antibody) is the therapeutic target
- Distinguished from all other Ig classes by being the only one that mediates allergic responses
All content sourced from: Harper's Illustrated Biochemistry, 32nd Edition (Murray et al.), Chapter 52, pp. 658-660
This is a shared conversation. Sign in to Orris to start your own chat.